My watch list  


DHA-clozapine (trade name Clozaprexin) is an atypical antipsychotic that has been developed by Protarga. The drug has been created by the association of fatty acid docosahexaenoic acid (DHA) with clozapine. The advantages of this drug is that until the DHA and clozapine are not separated the drug is inactive, once it penetrate the blood brain barrier the DHA and clozapine are freed from each others slowly by enzymatic activity and more clozapine is liberated where it is needed rendering the drug much more potent and longer active and requiring a much lower dosage which consequence is fewer side effects. The drug is not yet available.

See also


This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "DHA-clozapine". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE